Freshfields Bruckhaus Deringer and Maples Group are advising AstraZeneca on the transaction, and Cooley and Harney Westwood & Riegels are advising Gracell Biotechnologies.AstraZeneca announced it has…
AstraZeneca’s $1.2 Billion Acquisition of Gracell Biotechnologies
